Eurobarometer Qualitative Study: Patient Involvement

Eurobarometer Qualitative Study: Patient Involvement
European Commission published the results of the Qualitative Eurobarometer on patient involvement in healthcare. The aim of this research was to explore views on patient involvement in healthcare across fifteen European Member States. In-depth interviews were carried out with five healthcare practitioners and ten patients, in each country. This research was qualitative in nature and is therefore not intended to be representative of the views of either practitioners or patients in the participating countries. Conclusions reflect the experience and views of those who took part in the study.

Some key findings of the report:

  • The term "patient involvement" is not clearly understood by either patients or practitioners and often means different things to different people. Many patients describe a "traditional doctor-patient relationship", where the doctor's opinion is considered as being beyond questioning and patients feel uncomfortable giving feedback.
  • Communication is considered very important, but both patients and practitioners describe how doctors have insufficient time to explain treatment options.
  • The main risks of patient involvement, mentioned by both patients and practitioners, are increased demands on practitioners' time, and the possibility of patients disagreeing with doctors' opinions. This would also have financial implications.
  • The Internet is generally felt to be the area where there has been the most significant development with almost all patients now having greater access to information about their symptoms and healthcare (as well as healthcare options). This is seen as positive by patients but is more ambivalent for some practitioners.
  • Patients in Eastern European countries are most likely to be dissatisfied with their current level of involvement in healthcare and want to be more involved. However, this response is not universal.
  • Chronically ill patients tend to have more experience in self-monitoring and often have a more tangible understanding of "patient involvement".

This research was qualitative in nature and is therefore not intended to be representative of the views of either practitioners or patients in the participating countries. Conclusions reflect the experience and views of those who took part in the study. It provides interesting topics raised in the interviews about patient involvement in clinical practice.

Download Eurobarometer Qualitative Study: Patient Involvement (.pdf, 915 KB).

Download from eHealthNews.eu Portal's mirror: Eurobarometer Qualitative Study: Patient Involvement (.pdf, 915 KB).

Most Popular Now

Researchers Capture First Images of Oxyg…

Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful. Hypoxia, or starvation of oxygen, in solid tumors is also thought to be...

VTT Makes New Investments in Digital Hea…

VTT is launching new research activities in the area of digital health as part of the growing wellbeing and health technology ecosystem in Kuopio. The new initiative aims to create...

A New Method of Artificial Intelligence …

Despite the immense progress in the field of AI in recent years, we are still very far from human intelligence. Indeed, if current AI techniques allow to train computer agents...

FDA Informs Health Care Providers, Facil…

Today, the U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central...

eHealthWeek 2020 Croatia - Trusted Infor…

15 - 17 April 2020, Rovinj, Croatia. In its capacity of hosting the upcoming Presidency of the Council of the European Union, the Croatian Ministry of Health is in preparations to...

Siemens Healthineers Presents Solutions …

CT scanners with intelligent user guidance, AI-based software assistants for MRI and a lab system that revolutionizes workflows: Siemens Healthineers is showcasing its products and solutions according to the motto...

NHS IT Chiefs Set the Stage for a Year o…

3 - 4 March 2019, London, United Kingdom. NHS technology leaders are to kick off the second-ever Digital Health Rewired Conference and Exhibition on 3 - 4 March at the Olympia...

PatchAi Startup has Arrived in the Marke…

PatchAi - a startup that offers, thanks to Artificial Intelligence and Machine Learning, an empathic virtual assistant to patients participating in clinical trials - announced that it has closed two...

Digital Health App Medicus AI Earns CE C…

Medicus AI, the Vienna-based health tech company, has received a ​Class I Medical Device CE Mark for its mobile application. The CE certification mark confirms that Medicus AI conforms to...

FDA Authorizes Marketing of First Cardia…

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is...

Human Body-on-Chip Platform Enables In V…

Drug development is an extremely arduous and costly process, and failure rates in clinical trials that test new drugs for their safety and efficacy in humans remain very high. According...

AI in Drug Discovery Conference 2020

16 - 17 March 2020, London, UK. SMi group presents the launch of the inaugural AI in Drug Discovery conference taking place in London. AI-empowered machine learning technologies hold the potential...